Off-body Wearable Injectors Market

Off-body Wearable Injectors Market contains market size and forecasts of Off-body Wearable Injectors in global, including the following market information:

• Global Off-body Wearable Injectors Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Off-body Wearable Injectors Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Off-body Wearable Injectors companies in 2021 (%)

The global Off-body Wearable Injectors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Electronical Injectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Off-body Wearable Injectors include Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group and West Pharmaceutical Services, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Off-body Wearable Injectors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Off-body Wearable Injectors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Off-body Wearable Injectors Market Segment Percentages, by Type, 2021 (%)

• Electronical Injectors
• Mechanical Injectors
• Others

Global Off-body Wearable Injectors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Off-body Wearable Injectors Market Segment Percentages, by Application, 2021 (%)

• Immuno-oncology
• Diabetes
• Cardiovascular Diseases
• Other

Global Off-body Wearable Injectors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Off-body Wearable Injectors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Off-body Wearable Injectors revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Off-body Wearable Injectors revenues share in global market, 2021 (%)
• Key companies Off-body Wearable Injectors sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Off-body Wearable Injectors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Becton, Dickinson and Company
• Medtronic
• Johnson & Johnson
• Insulet Corporation
• Unilife Corporation
• Enable Injections
• SteadyMed
• Ypsomed Group
• West Pharmaceutical Services
• Unilife
• CeQur
• Sensile Medical
• Roche
• ScPharmaceuticals
• SteadyMed